medicaid
Medicaid, the US government's health program for low-income people, as a market for health insurers and providers.
Theme · 2 companies · 0 report it as a revenue line
Sells it“Medicaid attrition was primarily associated with eligibility redeterminations; Medicare Advantage declines also reflected deliberate repositioning.”
Latest 10-QQ3 FY2026Mixed ·
Carelon’s specialty pharmacy and care-services gains fell short of offsetting medical-cost pressure in Health Benefits.
- Revenue$51.4BYoY +1.4%
- Net income$1.4BYoY +14.8%
Latest 8-KGuidance reaffirmed ·
FY2026 outlook reaffirmed for investor meetings: EPS of at least $22.00 diluted and $29.00 adjusted.
Latest 8-KPositiveEarningsGuidance raised ·
Carelon growth contrasts with Health Benefits weakness; FY2026 adjusted EPS outlook raised to ≥$29
Latest 8-KEarningsGuidance raisedImpairment / charge ·
Government medical costs squeezed margins despite improved Individual ACA performance; management raised FY2026 guidance.
Sells it“Medicaid care activity—especially behavioral, pharmacy and home health—is outpacing state rate updates.”
Latest 10-QQ3 FY2026MixedRestructuring ·
Pricing and market exits shrink UnitedHealthcare membership; reserve releases and divestitures bolster Optum Health’s earnings.
- Revenue$112.7BYoY −0.4%
- Net income$4.1BYoY +75.0%
Latest 8-KLeadership change ·
Former Children’s Hospital of Philadelphia CEO Madeline Bell joins the board, bringing patient-care and hospital leadership experience.
Latest 8-KPositiveEarningsGuidance raised ·
UnitedHealthcare pricing and benefit changes lift earnings; FY2026 adjusted EPS outlook raised to at least $20.50
Latest 8-KInvestor update ·
Leaders will discuss strategy, recent results and end-market expectations at the Wells Fargo Healthcare Conference.
No companies have a recent 8-K matching these events.
No companies in the selected roles.